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Abstract 
Background: Both contrast media dose and osmolality may affect the degree of hyperemia 
and therefore diagnostic accuracy achieved with contrast fractional flow reserve (cFFR). 
Methods and Results: A total of 763 patients were prospectively enrolled from 12 
institutions. cFFR, instantaneous wave-free ratio (iFR), distal pressure/aortic pressure 
(Pd/Pa) at rest and FFR were measured. Patients were categorized by the osmolality and 
volume of contrast media: low- and iso-osmolality (n=574 and 189); low (<8 milliliters) and 
high volume (n=341 and 422). We compared the diagnostic performance of cFFR between 
the low- and iso-osmolality and between low and high volume contrast, and investigated its 
superiority over other resting indices using FFR ≤0.80 as a reference standard. Both the 
low- and iso-osmolality groups showed comparable diagnostic accuracy of cFFR (84.8% 
versus 88.8%) as did both the low and high contrast volume groups (83.2% versus 87.9%). 
By receiver operator characteristics curve analysis, cFFR provided better diagnostic 
performance than resting indices regardless of contrast osmolality and volume (P<0.001 
versus iFR and Pd/Pa for all groups). There was no significant difference between the area 
under the curve of cFFR in the low- and iso-osmolality groups (0.938 versus 0.957, P=0.40) 
and in the low and high volume contrast groups (0.939 versus 0.949, P=0.61). Multivariable 
logistic regression analysis showed that neither contrast osmolality nor volume significantly 
affected the diagnostic accuracy of cFFR. 
Conclusions: Contrast volume and osmolality do not affect the diagnostic accuracy of cFFR. 
These data suggest that cFFR can be broadly applied in most catheterization laboratories. 
 
 
Clinical Trial Registration URL: https://www.clinicaltrials.gov. Unique identifier: NCT02184117. 
 
  
 3 
 
Introduction 
Pressure-derived fractional flow reserve (FFR) is the reference standard in catheterization 
laboratories to assess the physiologic severity of coronary artery stenosis.1,2 FFR-guided 
therapy has been shown to improve patient outcomes by determining the appropriate 
selection of patients for percutaneous coronary intervention (PCI).3,4 For its accurate 
calculation, FFR requires maximal coronary hyperemia, usually achieved with adenosine.5-7 
However, cost, time, side effects or practical reasons associated with adenosine may limit 
the widespread utilization of FFR. Therefore, adenosine-free pressure-derived indices have 
been drawing attention.8-16 
The pressure ratio between the distal coronary artery and aorta during submaximal 
hyperemia induced by intracoronary injection of contrast medium, so-called contrast FFR 
(cFFR) emerged as an adenosine-free index and has been shown to be superior to other 
adenosine-free indices obtained at pure resting status in predicting FFR and reducing the 
use of adenosine.13-16 In addition, cFFR is immediately available using conventional contrast 
media routinely administered for coronary angiography and does not require special 
software or an electrocardiogram tracing.15,16 
However, there is a theoretical concern that both contrast dose and osmolality may 
affect the degree of hyperemia and therefore the diagnostic accuracy achieved with cFFR. In 
clinical practice, the type and dose of contrast media used for cardiac catheterization varies.  
We, therefore, performed this analysis to investigate the impact of contrast osmolality and 
dose on the diagnostic performance of cFFR. 
 
Methods 
Study design and population. 
The CONTRAST (Can contrast injection better approximate FFR compared to pure resting 
physiology?) study16 is a multi-center, prospective, investigator-initiated observational study, 
designed to evaluate the diagnostic performance of contrast FFR (cFFR), resting distal 
coronary pressure to aortic or proximal coronary pressure (Pd/Pa), and the instantaneous 
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wave-free ratio (iFR) to predict FFR (registered at clinicaltrials.gov: identifier NCT02184117). 
The current study enrolled 763 patients from the CONTRAST study who were 18 
years of age or older and underwent routine FFR assessment for standard indications. In 
cases of multivessel disease, only the first lesion studied using FFR was included. Exclusion 
criteria included prior coronary artery bypass surgery, known severe left ventricular 
hypertrophy (septal wall thickness >13 mm) or dysfunction (left ventricular ejection fraction 
<30%), extremely tortuous or calcified coronary arteries precluding intracoronary physiologic 
measurement, contraindication to adenosine, recent (within 3 weeks prior to cardiac 
catheterization) ST-segment elevation myocardial infarction, or renal insufficiency such that 
additional contrast would pose unwarranted risk. Culprit lesions for acute infarction were 
also excluded. This study was approved by an institutional review committee from each 
participating site, and each patient provided written informed consent. 
Coronary Physiology Procedure. 
All coronary physiologic parameters were measured with a 0.014-inch pressure sensor 
guidewire (PressureWire Certus or Aeris wire and the QUANTIEN system, St. Jude Medical). 
The pressure guidewire was advanced distal to the target lesion. The first measurements 
were made for at least 1 minute to record resting physiology. Next, an IC bolus of contrast 
medium was injected either manually or with an injector. The volume and type of IC contrast 
medium was not mandated but with a recommendation for 6 to 10 ml. Then, 100-200 μg of 
intracoronary adenosine was injected.17 Finally, intravenous (IV) adenosine was 
administered at140 μg/kg/min for 2 minutes via either a central or large-bore peripheral IV 
line. Each measurement was repeated twice in the same way with at least a one minute 
interval to ensure pressure recovery. Operators were encouraged to perform both IC and IV 
adenosine measurements in duplicate, but all 4 were not mandatory as long as at least one 
technique was repeated. All physiologic tracings were sent to an independent core 
laboratory (Cardiovascular Research Foundation, New York) for off-line analysis. The quality 
of pressure tracings and electrocardiographic data were carefully evaluated. FFR was 
measured as mean distal coronary pressure divided by aortic or proximal coronary pressure 
during maximal hyperemia with IC injection and IV infusion of adenosine; cFFR was 
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measured during submaximal hyperemia with IC injection of contrast; and Pd/Pa was 
measured at rest. The iFR was defined as the ratio of distal coronary pressure to aortic 
pressure during the wave-free period (approximately 75% of late diastole) at rest [8], 
automatically calculated by the core laboratory using HARVEST software (Volcano 
Corporation). Because there could be as many as 4 FFR values for each subject (2 IC and 2 
IV), a summary FFR value was computed by the following hierarchy: the average of 2 IV 
values, a single IV value, the average of 2 IC values, or a single IC value. When both test 
and retest values were present, their average was used. 
Study Endpoints. 
The primary purpose of this analysis was to investigate whether the osmolality and dose of 
contrast media impact the diagnostic performance of cFFR. The patients were categorized 
by the osmolality of contrast media used for cFFR measurement into two groups: 
low-osmolality (including Iobitridol, Iohexol, iomeprol, iopamidol, iopromide, ioversol, 
ioxaglate) and iso-osmolality group (including Iodixanol) and by the median value of contrast 
volume: high contrast volume (≥8 ml) and low contrast volume (<8 ml). 
 The significance of a coronary artery lesion based on adenosine-free indices was 
defined as cFFR ≤0.83, iFR <0.90, and Pd/Pa <0.92 according to previous studies.10,16 We 
explored the diagnostic performance of the hybrid strategy in which adenosine can be 
avoided for values above or below a defined threshold, but must be administered when the 
value falls within those limits (adenosine zone). The range of 0.83-0.88, 0.87-0.94 and 
0.89-0.95 was chosen for cFFR, iFR and Pd/Pa adenosine zone as used to achieve 94% 
rounded accuracy in CONTRAST study cohort.16 
Statistical Analysis. 
Continuous variables are presented as a median and interquartile range (IQR) and were 
compared with Mann-Whitney U test. Categorical variables are presented as counts and 
percentages and were compared using the Fisher’s exact test. Correlations between FFR 
and adenosine-free indices were tested with Pearson’s correlation coefficient. 
Receiver-operating characteristics (ROC) curve analysis was used to examine the 
diagnostic performance of cFFR, iFR and Pd/Pa as a predictor of FFR ≤0.80. The area 
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under the ROC curve (AUC) was compared with the method of DeLong et al. or Hanley & 
McNeil for correlated or uncorrelated curves, respectively.18,19 Multivariable logistic 
regression models were used to assess whether contrast osmolality and volume were 
predictors of diagnostic performance of cFFR. In the models, the diagnostic agreement 
between cFFR and FFR (agreement or not) in positive FFR, negative FFR, and entire 
patients were used as a dependent variable for sensitivity, specificity and accuracy, 
respectively, while contrast osmolality (iso- vs. low-osmolality) and volume (high vs. low 
volume) were used for independent variables. Statistical analysis was performed using SAS 
version 9.4 (SAS Institute, Cary, NC, USA). A value of P <0.05 was considered significant. 
 
Results 
Patient characteristics are presented in Tables 1A and 1B. There were 574 patients in the 
low-osmolality group versus 189 patients in the iso-osmolality group and 341 patients in the 
low contrast volume group versus 422 patients in the high contrast volume group. The 
median IC contrast volume was similar in the low- and iso-osmolality groups (8 [6-8] ml 
versus 8 [6-10] ml, P = 0.12). Iso-osmolality contrast was more frequently used in patients 
with advanced age, renal insufficiency, female sex, and dyslipidemia. Low volume contrast 
was more frequently used in patients with advanced age, female sex, hypertension, diabetes 
mellitus and dyslipidemia but without family history of coronary artery disease. The cFFR 
value was lower in the iso-osmolality group compared to the low-osmolality group. Pd/Pa, 
iFR, and FFR values were not significantly different between the two osmolality groups 
(Table 2A). The Pd/Pa, iFR and cFFR values were higher in the low contrast volume group 
compared to the high contrast volume group. The FFR value was not significantly different 
between the low and high contrast volume groups (Table 2B). 
Correlation and Agreement between the Adenosine-Free Indices and FFR. 
cFFR correlated well with FFR in both low- and iso-osmolality groups, as well as in both low 
and high volume contrast groups. Among the three adenosine-free indices, cFFR showed 
the highest correlation coefficient with FFR (Figure 1 and 2) and the best agreement with 
FFR with the smallest scatter of data by the Bland-Altman Plots (Figure 3 and 4) in all 
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groups. 
Comparisons of Diagnostic Accuracy of the Adenosine-Free Indices 
The results of the ROC analysis of cFFR, iFR, and Pd/Pa to predict FFR ≤0.80 are shown in 
Figure 5 and 6. When comparing AUC, cFFR provided better diagnostic performance than 
resting indices regardless of contrast osmolality or volume (P <0.001 versus iFR and Pd/Pa 
for all groups). There was no significant difference between the AUC of cFFR in the low- and 
iso-osmolality groups (0.938 versus 0.957, P = 0.40) and in the low and high volume 
contrast groups (0.939 versus 0.949, P = 0.61).  
Application of Binary Strategies and Effect of Contrast Osmolality and Volume 
When using a binary strategy with a defined threshold of cFFR ≤0.83, low osmolality 
contrast had lower sensitivity and slightly higher specificity than iso-osmolality contrast, as 
did low contrast volume compared to high contrast volume (Table 3). Multivariable logistic 
regression models showed that contrast osmolality and volume independently affected 
sensitivity and specificity of cFFR (Table 4). Sensitivity was likely to increase, and specificity 
was likely to decrease as contrast volume increased, or Iso-osmolalar contrast was used 
(versus low-osmolar). However, the overall diagnostic accuracy of cFFR was not 
significantly affected by contrast volume and osmolality. 
Application of Hybrid Strategies 
When employing a hybrid strategy, the diagnostic accuracy of cFFR-FFR hybrid strategy 
achieved similarly high values of 94.9% and 95.3% in the low- and iso-osmolality and 94.4 % 
and 95.4% in the low and high contrast volume groups with high sensitivity (91.4% and 
97.4% in the low- and iso-osmolality; and 89.7% and 95.4% in the low and high contrast 
volume groups) and high specificity (98.4% and 93.6% in the low- and iso-osmolality; and 
95.4% and 99.3% in the low and high contrast volume groups). Furthermore, the 
percentages of patients requiring adenosine were less than 30% in all groups: 25.5% and 
28.4% in the low- and iso-osmolality and 22.4% and 29.4% in the low and high contrast 
volume groups. On the other hand, 42.8 or 46.0% of patients needed adenosine for iFR-FFR 
or Pd/Pa-FFR hybrid strategies. Multivariable logistic regression revealed that neither 
contrast osmolality (Odds ratio 1.089 [95% confidence interval: 0.483 — 2.45]) nor volume 
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(Odds ratio 1.237 [0.620 — 2.466]) was associated with the diagnostic agreement of 
cFFR-FFR hybrid strategy with a minimal effect of contrast osmolality and volume on 
sensitivity (odds ratio of osmolality 3.955 [0.901 – 17.326] and odds ratio of volume 2.618 
[1.080 – 6.341]) and specificity (odds ratio of osmolality 0.274 [0.075 – 1.006] and odds ratio 
of volume 0.165 [0.020 – 1.329]).  
 
Discussion 
The main finding of this study is that the diagnostic accuracy of cFFR in comparison to FFR 
is not affected by contrast osmolality or volume. cFFR has better diagnostic accuracy than 
iFR and Pd/Pa regardless of whether low- or iso-osmolalar contrast is used and whether low 
or high volume contrast is injected. Both contrast osmolality and volume affect sensitivity 
and specificity of cFFR, but in opposite directions such that the overall diagnostic accuracy 
is not different between the low or iso-osmolar agents or between low or high volume 
injection. 
Previous studies have shown that cFFR has greater diagnostic accuracy than other 
resting adenosine-free indices, however the contrast osmolality and volume used to 
measure cFFR in those studies varied.13-16 In theory, both contrast osmolality and volume 
injected might affect the degree of hyperemia achieved when measuring cFFR and therefore 
impact its diagnostic accuracy.20,21  The mechanism by which contrast media induce 
submaximal hyperemia is not entirely clear but presumed to be partially due to transient 
hypoxia from replacement of oxygenated blood and partially due to stimulating endothelial 
paracrine pathways.17  
In the present study, greater contrast volume and lower osmolality were associated 
with an upward trend in sensitivity and a downward trend in specificity, which may mean that 
higher contrast volume and lower osmolar contrast result in greater hyperemia. With respect 
to the hyperemic effect of contrast osmolality, one might think that higher osmolar contrast 
would be more hyperemic, however iodixanol an iso-osmolar contrast (lower osmolality than 
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low osmolar contrast agents), has higher viscosity than the low-osmolality contrast media,22 
which might contribute to its greater hyperemia since viscosity of the contrast media directly 
influences the endothelium-derived vasodilatory response of the coronary vasculature and 
therefore the degree of hyperemia.23 
Previous studies have investigated the influence of contrast dose on 
contrast-induced hyperemia, but mostly using older contrast agents different from 
contemporary, lower osmolar contrast.21,24 A recent study tested progressive contrast doses 
(3, 6, 10, and 15 ml) of iodixanol in 12 left coronary lesions, showing that the percentage of 
cFFR relative to Pd/Pa decreased as contrast dose increased from 3, 6 to 10 ml.14 The result 
was in line with our study, suggesting the presence of a dose-response relationship between 
contrast volume and degree of contrast-induced hyperemia in the dose range typically used 
during coronary angiography. Although the overall diagnostic accuracy of cFFR did not 
change based on the volume or osmolality of the contrast media injected, Table 3 shows that 
the sensitivity of cFFR was higher in patients receiving higher contrast volume, while 
specificity was lower. Likewise, the sensitivity of cFFR was higher in patients receiving 
iso-osmolar contrast compared to those receiving low osmolar contrast. It is important to 
note that the same patients were not randomized to high or low volume contrast or to low or 
iso-osmolar contrast. For this reason, the patients who received higher volumes of contrast 
were different from those who received lower volume contrast, for example, and these 
differences contribute to the changes in sensitivity and specificity which were observed. 
Because the relationship between sensitivity and specificity is a trade-off relation, 
our threshold of cFFR≤0.83 was chosen to maximize accuracy, not to maximize either just 
sensitivity or just specificity. . Another method of using cFFR simply applies the FFR 
threshold, namely cFFR≤0.80. In this case, cFFR reaches 100% specificity (all cFFR 
positive lesions are FFR positive) but with reduced sensitivity (some cFFR negative lesions 
are still FFR positive due to more potent hyperemia with adenosine). Therefore the 
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differences in sensitivity and specificity represent tradeoffs on the ROC curve, which 
different operators may weight differently (a 'rule-in' versus 'rule-out' threshold) from our 
choice to maximize accuracy. Although contrast volume and osmolality affect the sensitivity 
and specificity of cFFR, because these parameters change in opposite directions the overall 
diagnostic performance of the binary strategy of cFFR is not affected to a great degree by 
contrast volume injected or osmolality. However, if one is most interested in achieving a high 
sensitivity then a higher contrast volume and a lower osmolality increase the sensitivity of 
cFFR. Likewise, if one is most interested in achieving a high specificity then a lower contrast 
volume and a higher osmolality increase the specificity of cFFR. 
It is challenging to determine the reason for the lower cFFR in patients receiving 
higher volume of contrast (Table 2B). At first glance, one might conclude that this is a result 
of greater hyperemia with a larger volume of contrast. However, unfortunately patients were 
not randomized to lower or higher volumes of contrast, which means that we cannot assume 
the difference is due to a greater hyperemic effect in patients receiving a higher volume of 
contrast, because it may be due to the significant differences in baseline characteristics 
between the two groups (Table 1B). For example, there were significantly more diabetic, 
hypertensive, dyslipidemic, and female patients who received a lower volume of contrast. All 
of these clinical characteristics have been associated with microvascular dysfunction; this 
may explain the higher cFFR value in the patients who received the lower volume of contrast. 
It may also explain the significantly higher Pd/Pa and iFR seen in the low volume contrast 
group compared to the high volume contrast group, differences which clearly are not related 
to contrast volume. Why FFR did not change as well may be due to higher resting flow in the 
patients who received high volume contrast, which could explain the lower values recorded 
with the adenosine-free indices. Once adenosine is administered, it abolishes any 
contribution of resting flow and FFR values may therefore be no different between the two 
groups.  
With respect to the higher cFFR seen in the low osmolality group compared with the 
iso-osmolality group (Table 2A), again we cannot assume that this is due to an effect of the 
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osmolality. This is because the patients were not randomized to low osmolality or 
iso-osmolality contrast and therefore, as mentioned above, differences in baseline clinical 
characteristics might explain the difference in cFFR. 
As FFR is the reference standard, a binary strategy of cFFR during submaximal 
hyperemia achieved a diagnostic accuracy of 85 to 90%.13-16 Employing a cFFR-FFR hybrid 
strategy can raise the accuracy to around 95%.13-16 The present study showed that the 
diagnostic accuracy of the hybrid strategy was not significantly affected by contrast volume 
or osmolality, and avoids adenosine in over 70% of patients. 
 
Limitations 
Our study has several limitations. First, the present study is a non-randomized, post hoc 
analysis of the CONTRAST study. Therefore, the results should be interpreted as 
hypothesis generating. A randomized study comparing volume and osmolality of contrast 
media injected in the same patients would help to clarify whether or not any real differences 
exist in diagnostic accuracy, as well as sensitivity and specificity of cFFR. Second, we did 
not investigate the impact of the differences in other factors of contrast media such as pH or 
ionicity. Third, because the cutoff values for both binary and hybrid strategies are derived 
from the CONTRAST study, the reproducibility of the results should be evaluated in other 
cohorts. Fourth, contrast volume between 6 to 10 ml was used in almost 98% of cases in the 
CONTRAST study, thus, the result of this study cannot be extrapolated to smaller or larger 
contrast volume. Fifth, because the protocol did not stipulate that operators measure the 
exact amount of contrast used with each cFFR measurement, but asked operators to 
provide an estimate of the contrast volume, there is some degree of uncertainty surrounding 
the volume administered. Finally, the diagnostic accuracy is influenced by disease 
prevalence (i.e. in this study the prevalence of positive FFR [≤0.80]). However, as the 
prevalence of positive FFR was similar between iso- and low-osmolality groups, we used the 
models for accuracy to look at the effect of osmolality and volume on the accuracy of cFFR. 
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Conclusion 
Neither contrast volume nor osmolality significantly affect the overall diagnostic accuracy of 
cFFR. cFFR should be broadly applicable in clinical practice when operators prefer to avoid 
adenosine for physiological lesion assessment. However, if one is most interested in 
achieving either high sensitivity alone or high specificity alone for cFFR, then contrast 
volume and osmolality can be important. 
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Table 1A. Patient Characteristics in Low and Iso-osmolality Groups. 
 
Overall 
(n = 763) 
Low-osmolality 
(n = 574) 
Iso-osmolality 
(n = 189) 
P 
value 
Age, years 
Male, n (%) 
Current smoking, n (%) 
Hypertension, n (%) 
Dyslipidemia, n (%) 
Diabetes mellitus, n (%) 
Family history, n (%) 
Renal insufficiency, n (%) 
Previous MI 
Coronary vessel 
Left main 
LAD 
LCx 
RCA 
Contrast volume 
67 (58-73) 
547 (72) 
146 (19) 
545 (71) 
508 (67) 
219 (29) 
191 (25) 
74 (10) 
198 (26) 
 
25 (3) 
460 (60) 
138 (18) 
140 (18) 
8 (6-10) 
66 (57-73) 
433 (75) 
114 (20) 
406 (71) 
366 (64) 
162 (28) 
164 (29) 
37 (7) 
158 (28) 
 
21 (4) 
339 (59) 
105 (18) 
109 (19) 
8 (6-10) 
 68 (63-74) 
114 (60) 
32 (17) 
139 (74) 
142(75) 
57 (30) 
27 (14) 
37 (20) 
40 (21) 
 
4 (2) 
121 (64) 
33 (18) 
31 (16) 
8 (6-8) 
0.002 
<0.001 
0.40 
0.52 
0.004 
0.64 
<0.001 
<0.001 
0.086 
0.59 
 
 
 
 
0.12 
Stenosis Classification by Angiography 0.27 
≤70% 
71 – 90% 
91 – 99% 
unknown 
677 (88.7) 
77 (10.1) 
5 (0.7) 
4 (0.5) 
512 (89.2) 
57 (9.9) 
2 (0.4) 
3 (0.5) 
165 (87.3) 
20 (10.6) 
3 (1.6) 
1 (0.5) 
 
Values are median (interquartile range) or n (%). IC, intracoronary; LAD, left anterior descending coronary 
artery; LCx, left circumflex coronary artery; MI, myocardial infarction, RCA, right coronary artery. 
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Table 1B. Patient Characteristics in Low and High Contrast Volume Groups. 
 
Overall 
(n = 763) 
Low volume 
(n = 341) 
High volume 
(n = 422) 
P 
value 
Age, years 
Male, n (%) 
Current smoking, n (%) 
Hypertension, n (%) 
Dyslipidemia, n (%) 
Diabetes mellitus, n (%) 
Family history, n (%) 
Renal insufficiency, n (%) 
Previous MI 
Coronary vessel 
Left main 
LAD 
LCx 
RCA 
Contrast volume 
Iso-osmolality contrast 
67 (58-73) 
547 (72) 
146 (19) 
545 (71) 
508 (67) 
219 (29) 
191 (25) 
74 (10) 
198 (26) 
 
25 (3) 
460 (60) 
138 (18) 
140 (18) 
8 (6-10) 
189 (25) 
66 (58-73) 
223 (65) 
70 (21) 
269 (79) 
 252 (74) 
114 (33) 
73 (21) 
38 (11) 
92 (27) 
 
10 (3) 
195 (57) 
69 (20) 
67 (20) 
6 (6-7) 
81 (24) 
67 (59-73) 
324 (77) 
76 (18) 
276 (65) 
256(61) 
105 (25) 
118 (28) 
36 (9) 
106 (25) 
 
15 (4) 
265 (63) 
69 (16) 
73 (17) 
10 (8-10) 
108 (26) 
0.002 
0.001 
0.41 
<0.001 
0.001 
0.010 
0.044 
0.27 
0.56 
0.34 
 
 
 
 
<0.001 
0.61 
Stenosis Classification by Angiography 0.32 
≤70% 
71 – 90% 
91 – 99% 
unknown 
677 (88.7) 
77 (10.1) 
5 (0.7) 
4 (0.5) 
303 (88.9) 
35 (10.3) 
3 (0.9) 
0 (0.0) 
374 (88.6) 
42 (10.0) 
2 (0.5) 
4 (1.0) 
 
Values are median (interquartile range) or n (%). IC, intracoronary; LAD, left anterior descending coronary 
artery; LCx, left circumflex coronary artery; MI, myocardial infarction, RCA, right coronary artery. 
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Table 2A. Pressure Wire Indices in Low and Iso-osmolality Groups. 
 
Overall 
(n = 763) 
Low osmolality 
(n = 574) 
Iso osmolality 
(n = 189) 
P value 
Pd/Pa 
iFR 
cFFR 
FFR 
0.92 (0.88 – 0.95) 
0.90 (0.85 – 0.94) 
0.86 (0.79 – 0.91) 
0.81 (0.74 – 0.87) 
0.92 (0.88 – 0.93) 
0.90 (0.85 – 0.95) 
0.86 (0.80 – 0.91) 
0.80 (0.73 – 0.86) 
0.92 (0.88 – 0.95) 
0.89 (0.84 – 0.94) 
0.84 (0.78 – 0.90) 
0.83 (0.74 – 0.88) 
0.16 
0.060 
0.029 
0.21 
Values are median (interquartile range). cFFR, contrast-based fractional flow reserve; FFR, fractional flow 
reserve; iFR, instantaneous wave-free ratio; Pd/Pa, distal pressure / aortic pressure. 
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Table 2B. Pressure Wire Indices in Low and High Contrast Volume Groups. 
 
Overall 
(n = 763) 
Low volume 
(n = 341) 
High volume 
(n = 422) 
P value 
Pd/Pa 
iFR 
cFFR 
FFR 
0.92 (0.88 – 0.95) 
0.90 (0.85 – 0.94) 
0.86 (0.79 – 0.91) 
0.81 (0.74 – 0.87) 
0.93 (0.89 – 0.96) 
0.91 (0.86 – 0.95) 
0.87 (0.80 – 0.92) 
0.80 (0.74 – 0.87) 
0.92 (0.88 – 0.95) 
0.89 (0.83 – 0.94) 
0.85 (0.79 – 0.89) 
0.81 (0.73 – 0.87) 
0.004 
0.001 
0.001 
0.88 
Values are median (interquartile range). cFFR, contrast-based fractional flow reserve; FFR, fractional flow 
reserve; iFR, instantaneous wave-free ratio; Pd/Pa, distal pressure / aortic pressure. 
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Table 3. Diagnostic performance of cFFR using a binary threshold of cFFR≤0.83 and 
AUC of cFFR for predicting FFR ≤0.80. 
 Sensitivity Specificity Accuracy AUC 
Low-osmolality group 
Iso-osmolality group 
Low contrast volume 
High contrast volume 
72.6% 
86.8% 
68.6% 
82.3% 
97.2% 
90.3% 
98.6% 
92.9% 
84.8% 
88.8% 
83.2% 
87.9% 
0.938 
0.957 
0.939 
0.949 
AUC, area under the receiver operating characteristic curve; cFFR, contrast-based fractional flow 
reserve; FFR, fractional flow reserve. 
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Table 4.  Effects of contrast osmolality and volume on the diagnostic performance of 
cFFR. 
  Odds ratio 95% CI P value 
Sensitivity 
Contrast osmolality (iso vs. low) 
Contrast volume (high vs. low) 
Specificity 
Contrast osmolality (iso vs. low) 
Contrast volume (high vs. low) 
Accuracy 
Contrast osmolality (iso vs. low) 
Contrast volume (high vs. low) 
 
86.8% vs. 72.6% 
82.3% vs. 68.6% 
 
90.3% vs. 97.2% 
92.9% vs. 98.6% 
 
88.8% vs. 84.8% 
87.9% vs. 83.2% 
 
2.839 
2.343 
 
0.308 
0.204 
 
1.414 
1.462 
 
1.364 – 5.908 
1.386 – 3.961 
 
0.110 – 0.864 
0.045 – 0.919 
 
0.827 – 2.418 
0.947 – 2.256 
 
0.005 
0.002 
 
0.025 
0.039 
 
0.21 
0.086 
cFFR, contrast-based fractional flow reserve; CI, confidence interval. 
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Figure 1.  Correlation between Fractional Flow Reserve and Adenosine-free 
Indices in Low- and Iso-osmolality Contrast. 
cFFR, contrast-based fractional flow reserve; iFR, instantaneous wave-free ratio; FFR, 
fractional flow reserve; Pd/Pa, distal pressure / aortic pressure at rest. 
 
Figure 2.  Correlation between Fractional Flow Reserve and Adenosine-free 
Indices in Low and High Contrast Volume. 
Abbreviations were same as Figure 1. 
 
Figure 3. Bland-Altman Plot between Fractional Flow Reserve and 
Adenosine-free Indices in Low- and Iso-osmolality Contrast. 
Bias (mean difference) between two indices is shown in solid line and 95% limits of 
agreement (LOA) are shown in dotted lines. cFFR, contrast-based fractional flow reserve; 
FFR, fractional flow reserve; iFR, instantaneous wave-free ratio; LOA, 95% limits for 
agreement; Pd/Pa=rest distal pressure/aortic pressure. 
 
Figure 4. Bland-Altman plot between fractional flow reserve and adenosine-free 
indices in low and high contrast volume. 
Abbreviations were same as Figure 3. 
 
Figure 5.  Receiver operator characteristics curve analysis of adenosine-free 
indices to predict fractional flow reserve ≤0.80 in low- and iso-osmolality contrast 
groups. 
The AUC of cFFR was the greatest among the adenosine-free indices in both low- and 
iso-osmolality group (all P <0.001). There was no significant difference between the AUC of 
cFFR in the low- and iso-osmolality group (P = 0.40). 
AUC, area under the receiver operator characteristics curve; cFFR, contrast-based 
fractional flow reserve; CI, confidence interval; iFR, instantaneous wave-free ratio; FFR, 
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fractional flow reserve; Pd/Pa, distal pressure/aortic pressure at rest. 
 
Figure 6.  Receiver Operator Characteristics Curve Analysis of Adenosine-free 
Indices to Predict Fractional Flow Reserve ≤0.80 in the Low and High Contrast Volume 
Groups. 
The AUC of cFFR was the greatest among the adenosine-free indices in both low and high 
contrast volume groups (all P <0.001). There was no significant difference between the AUC 
of cFFR in the low- and iso-osmolality group (P = 0.61).  
Abbreviations were same as Figure 5. 
 
 
 
